An ethical code for collecting, using and transferring sensitive health data: outcomes of a modified Policy Delphi process in Singapore
Abstract One of the core goals of Digital Health Technologies (DHT) is to transform healthcare services and delivery by shifting primary care from hospitals into the community. However, achieving this goal will rely on the collection, use and storage of large datasets. Some of these datasets will be linked to multiple sources, and may include highly sensitive health information that needs to be transferred across institutional and jurisdictional boundaries. The growth of DHT has outpaced the establishment of clear legal pathways to facilitate the collection, use and transfer of potentially sensitive health data. Our study aimed to address this gap with an ethical code to guide researchers developing DHT with international collaborative partners in Singapore. We generated this code using a modified Policy Delphi process designed to engage stakeholders in the deliberation of health data ethics and governance. This paper reports the outcomes of this process along with the key components of the code and identifies areas for future research..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
BMC medical ethics - 24(2023), 1 vom: 04. Okt. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lysaght, Tamra [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Bioethics |
|---|
| Anmerkungen: |
© The Author(s) 2023 |
|---|
| doi: |
10.1186/s12910-023-00952-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR053305272 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR053305272 | ||
| 003 | DE-627 | ||
| 005 | 20231121064838.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231006s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12910-023-00952-7 |2 doi | |
| 035 | |a (DE-627)SPR053305272 | ||
| 035 | |a (SPR)s12910-023-00952-7-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lysaght, Tamra |e verfasserin |4 aut | |
| 245 | 1 | 3 | |a An ethical code for collecting, using and transferring sensitive health data: outcomes of a modified Policy Delphi process in Singapore |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2023 | ||
| 520 | |a Abstract One of the core goals of Digital Health Technologies (DHT) is to transform healthcare services and delivery by shifting primary care from hospitals into the community. However, achieving this goal will rely on the collection, use and storage of large datasets. Some of these datasets will be linked to multiple sources, and may include highly sensitive health information that needs to be transferred across institutional and jurisdictional boundaries. The growth of DHT has outpaced the establishment of clear legal pathways to facilitate the collection, use and transfer of potentially sensitive health data. Our study aimed to address this gap with an ethical code to guide researchers developing DHT with international collaborative partners in Singapore. We generated this code using a modified Policy Delphi process designed to engage stakeholders in the deliberation of health data ethics and governance. This paper reports the outcomes of this process along with the key components of the code and identifies areas for future research. | ||
| 650 | 4 | |a Health data ethics |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Bioethics |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Ethical guidelines |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Health data |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Data sensitivity |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Modified Policy Delphi |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a International data transfer |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Chan, Hui Yun |4 aut | |
| 700 | 1 | |a Scheibner, James |4 aut | |
| 700 | 1 | |a Toh, Hui Jin |4 aut | |
| 700 | 1 | |a Richards, Bernadette |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC medical ethics |d London : BioMed Central, 2000 |g 24(2023), 1 vom: 04. Okt. |w (DE-627)SPR028192354 |w (DE-600)2041552-7 |x 1472-6939 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2023 |g number:1 |g day:04 |g month:10 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/s12910-023-00952-7 |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2023 |e 1 |b 04 |c 10 | ||